Maryland | 001-33549 | 38-3754322 | ||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||
299 Park Avenue, 13th Floor New York, New York | 10171 | |
(Address of Principal Executive Offices) | (Zip Code) | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock, par value $0.001 per share | TIPT | Nasdaq Capital Market |
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 | Results of Operations and Financial Condition. |
Item 7.01 | Regulation FD Disclosure. |
Item 9.01 | Financial Statements and Exhibits. |
TIPTREE INC. | |||
Date: | March 11, 2020 | By: | /s/ Jonathan Ilany |
Name: Jonathan Ilany | |||
Title: Chief Executive Officer | |||

• | Revenues of $208.5 million for Q4’19 and $772.7 million for FY’19, up 36.8% and 23.5%, respectively from Q4’18 and from FY’18. |
• | Net income of $4.2 million for Q4’19, up from $0.1 million in Q4’18, driven by growth in our Insurance operations and improved returns in Tiptree Capital. Net income of $18.4 million for FY’19, down $5.5 million from prior year driven by non-recurring gain from sale of Care in 2018, partially offset by improved performance in Insurance operations and Tiptree Capital. |
• | Operating EBITDA(1) of $21.0 million for the quarter and $63.6 million for the year, an increase of 26.5% and 15.8%, respectively, from Q4’18 and FY’18, driven by growth in insurance operations and contributions from our shipping and mortgage operations within Tiptree Capital. |
• | Book value per share as of December 31, 2019 was $11.52, which including dividends paid represents a 8.2%(2) year over year return. |
• | Declared a dividend of $0.04 per share to stockholders of record on March 23, 2020 with a payment date of March 30, 2020. |
Summary Consolidated Statements of Operations | |||||||||||||||
($ in millions, except per share information) | Three Months Ended December 31, | Year Ended December 31, | |||||||||||||
GAAP: | 2019 | 2018 | 2019 | 2018 | |||||||||||
Total revenues | $ | 208.5 | $ | 152.4 | $ | 772.7 | $ | 625.8 | |||||||
Net income attributable to Common Stockholders | $ | 4.2 | $ | 0.1 | $ | 18.4 | $ | 23.9 | |||||||
Diluted earnings per share | $ | 0.11 | $ | 0.01 | $ | 0.50 | $ | 0.69 | |||||||
Cash dividends paid per common share | $ | 0.040 | $ | 0.035 | $ | 0.155 | $ | 0.135 | |||||||
Non-GAAP: (1) | |||||||||||||||
Operating EBITDA | $ | 21.0 | $ | 16.6 | $ | 63.6 | $ | 54.9 | |||||||
Adjusted EBITDA | $ | 19.3 | $ | 5.6 | $ | 63.0 | $ | 28.8 | |||||||
Book value per share | $ | 11.52 | $ | 10.79 | $ | 11.52 | $ | 10.79 | |||||||
• | Delivered total annual return of 8.2%, as measured by growth in book value per share plus dividends paid. |
• | In 2019, we purchased and retired 1,472,730 shares of our Common Stock for $9.1 million. |
• | Increased our dividends for the third consecutive year to $0.155 per share, a 14.8% increase over the prior year. |
• | Gross written premiums for 2019 were $1,015 million, up 17.0% from the prior year. Net written premiums were $537.2 million, up 15.1%, driven by growth in all product lines. |
• | Our insurance investments earned a total return of 5.4%, up from 0.3% from the prior year period, driven primarily by improved mark-to-market on equities and fixed income investments. |
• | In January 2020, we acquired Smart AutoCare, a growing vehicle warranty administrator in the United States. The transaction valued the business at $160 million of enterprise value, inclusive of $50 million of earn out consideration, representing a multiple of 8.3x modified cash EBITDA (excluding anticipated revenue and expense synergies). |
• | As part of our strategy to grow our insurance operations in Europe, in July 2019, we acquired a majority interest in Defend, an automotive finance and insurance administrator operating in the Czech Republic, Poland, Hungary, Slovakia, and the UK. |
• | Operating EBITDA grew year over year, driven primarily by the inclusion of a full year of our maritime transportation operations and improvements in specialty finance. |
• | Increased invested capital, primarily due to additional investments in vessels. |
($ in millions) | Three Months Ended December 31, | Year Ended December 31, | |||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Net realized and unrealized gains (losses)(1) | $ | 0.6 | $ | (7.4 | ) | $ | 9.8 | $ | (14.0 | ) | |||||
Net realized and unrealized gains (losses) - Invesque | $ | 0.5 | $ | (10.7 | ) | $ | (1.2 | ) | $ | (20.7 | ) | ||||
Discontinued operations (Care)(2) | $ | — | $ | 10.7 | $ | — | $ | 57.5 | |||||||
($ in millions) | Three Months Ended December 31, | Year Ended December 31, | |||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Tiptree Insurance | $ | 12.6 | $ | 2.8 | $ | 41.0 | $ | 18.6 | |||||||
Tiptree Capital | 4.8 | (6.6 | ) | 21.0 | (7.8 | ) | |||||||||
Corporate | (7.5 | ) | (9.4 | ) | (32.9 | ) | (30.6 | ) | |||||||
Pre-tax income (loss) from continuing operations | $ | 9.9 | $ | (13.2 | ) | $ | 29.1 | $ | (19.8 | ) | |||||
Pre-tax income (loss) from discontinued operations (1) | $ | — | $ | 10.7 | $ | — | $ | 57.5 | |||||||
(1) | Represents Care for the year ended December 31, 2018 which includes $56.9 million pre-tax gain on sale. |
($ in millions) | Three Months Ended December 31, | Year Ended December 31, | |||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Tiptree Insurance | $ | 18.8 | $ | 19.4 | $ | 63.3 | $ | 64.5 | |||||||
Tiptree Capital (2) | 7.5 | 2.3 | 22.8 | 13.7 | |||||||||||
Corporate | (5.3 | ) | (5.1 | ) | (22.5 | ) | (23.3 | ) | |||||||
Operating EBITDA | $ | 21.0 | $ | 16.6 | $ | 63.6 | $ | 54.9 | |||||||
(1) | For further information relating to the Company’s Operating EBITDA, including a reconciliation to GAAP pre-tax income, see “—Non-GAAP Reconciliations.” |
(2) | Includes discontinued operations related to Care. As of February 1, 2018, invested capital from Care discontinued operations is represented by our investment in Invesque common shares. For more information, see “Note—(3) Dispositions, Assets Held for Sale and Discontinued Operations” in our Form 10-K for the year ended December 31, 2019. |
As of December 31, | |||||||
2019 | 2018 | ||||||
Assets: | |||||||
Investments: | |||||||
Available for sale securities, at fair value | $ | 335,192 | $ | 283,563 | |||
Loans, at fair value | 108,894 | 215,383 | |||||
Equity securities | 155,378 | 122,979 | |||||
Other investments | 137,472 | 75,002 | |||||
Total investments | 736,936 | 696,927 | |||||
Cash and cash equivalents | 133,117 | 86,003 | |||||
Restricted cash | 11,473 | 10,521 | |||||
Notes and accounts receivable, net | 286,968 | 223,105 | |||||
Reinsurance receivables | 539,833 | 420,351 | |||||
Deferred acquisition costs | 166,493 | 170,063 | |||||
Goodwill | 99,147 | 91,562 | |||||
Intangible assets, net | 47,974 | 52,121 | |||||
Other assets | 68,510 | 46,034 | |||||
Assets held for sale | 107,835 | 68,231 | |||||
Total assets | $ | 2,198,286 | $ | 1,864,918 | |||
Liabilities and Stockholders’ Equity | |||||||
Liabilities: | |||||||
Debt, net | $ | 374,454 | $ | 354,083 | |||
Unearned premiums | 754,993 | 599,444 | |||||
Policy liabilities and unpaid claims | 144,384 | 131,611 | |||||
Deferred revenue | 94,601 | 75,754 | |||||
Reinsurance payable | 143,869 | 117,597 | |||||
Other liabilities and accrued expenses | 172,140 | 124,190 | |||||
Liabilities held for sale | 102,430 | 62,980 | |||||
Total liabilities | $ | 1,786,871 | $ | 1,465,659 | |||
Stockholders’ Equity: | |||||||
Preferred stock: $0.001 par value, 100,000,000 shares authorized, none issued or outstanding | $ | — | $ | — | |||
Common Stock: $0.001 par value, 200,000,000 shares authorized, 34,562,553 and 35,870,348 shares issued and outstanding, respectively | 35 | 36 | |||||
Additional paid-in capital | 326,140 | 331,892 | |||||
Accumulated other comprehensive income (loss), net of tax | 1,698 | (2,058 | ) | ||||
Retained earnings | 70,189 | 57,231 | |||||
Total Tiptree Inc. stockholders’ equity | 398,062 | 387,101 | |||||
Non-controlling interests - Other | 13,353 | 12,158 | |||||
Total stockholders’ equity | 411,415 | 399,259 | |||||
Total liabilities and stockholders’ equity | $ | 2,198,286 | $ | 1,864,918 | |||
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenues: | |||||||||||||||
Earned premiums, net | $ | 134,396 | $ | 109,995 | $ | 499,108 | $ | 427,837 | |||||||
Service and administrative fees | 27,558 | 26,680 | 106,239 | 102,315 | |||||||||||
Ceding commissions | 2,458 | 2,869 | 9,608 | 9,651 | |||||||||||
Net investment income | 3,304 | 5,237 | 14,017 | 19,179 | |||||||||||
Net realized and unrealized gains (losses) | 25,122 | (3,130 | ) | 83,868 | 28,782 | ||||||||||
Other revenue | 15,730 | 10,726 | 59,888 | 38,062 | |||||||||||
Total revenues | 208,568 | 152,377 | 772,728 | 625,826 | |||||||||||
Expenses: | |||||||||||||||
Policy and contract benefits | 46,425 | 36,804 | 170,681 | 152,095 | |||||||||||
Commission expense | 77,987 | 68,043 | 303,057 | 262,460 | |||||||||||
Employee compensation and benefits | 35,181 | 29,611 | 129,479 | 113,557 | |||||||||||
Interest expense | 6,876 | 7,078 | 27,059 | 27,013 | |||||||||||
Depreciation and amortization | 3,661 | 3,486 | 13,569 | 12,596 | |||||||||||
Other expenses | 28,561 | 20,547 | 99,744 | 77,901 | |||||||||||
Total expenses | 198,691 | 165,569 | 743,589 | 645,622 | |||||||||||
Income (loss) before taxes from continuing operations | 9,877 | (13,192 | ) | 29,139 | (19,796 | ) | |||||||||
Less: provision (benefit) for income taxes | 5,311 | (4,431 | ) | 9,017 | (5,909 | ) | |||||||||
Net income (loss) from continuing operations | 4,566 | (8,761 | ) | 20,122 | (13,887 | ) | |||||||||
Discontinued operations: | |||||||||||||||
Income (loss) before taxes from discontinued operations | — | — | — | 624 | |||||||||||
Gain on sale of discontinued operations | — | 10,676 | — | 56,860 | |||||||||||
Less: Provision (benefit) for income taxes | 1,387 | — | 13,714 | ||||||||||||
Net income (loss) from discontinued operations | — | 9,289 | — | 43,770 | |||||||||||
Net income (loss) before non-controlling interests | 4,566 | 528 | 20,122 | 29,883 | |||||||||||
Less: net income (loss) attributable to non-controlling interests - TFP | — | — | — | 5,500 | |||||||||||
Less: net income (loss) attributable to non-controlling interests - Other | 419 | 363 | 1,761 | 450 | |||||||||||
Net income (loss) attributable to Common Stockholders | $ | 4,147 | $ | 165 | $ | 18,361 | $ | 23,933 | |||||||
Net income (loss) per Common Share: | |||||||||||||||
Basic, continuing operations, net | $ | 0.12 | $ | (0.25 | ) | $ | 0.52 | $ | (0.38 | ) | |||||
Basic, discontinued operations, net | — | 0.26 | — | 1.07 | |||||||||||
Basic earnings per share | $ | 0.12 | $ | 0.01 | $ | 0.52 | $ | 0.69 | |||||||
Diluted, continuing operations, net | 0.11 | (0.25 | ) | 0.50 | (0.38 | ) | |||||||||
Diluted, discontinued operations, net | — | 0.26 | — | 1.07 | |||||||||||
Diluted earnings per share | $ | 0.11 | $ | 0.01 | $ | 0.50 | $ | 0.69 | |||||||
Weighted average number of Common Shares: | |||||||||||||||
Basic | 34,562,219 | 35,921,632 | 34,578,292 | 34,715,852 | |||||||||||
Diluted | 34,578,357 | 35,921,632 | 34,578,292 | 34,715,852 | |||||||||||
Dividends declared per Common Share | $ | 0.040 | $ | 0.035 | $ | 0.16 | $ | 0.14 | |||||||
($ in millions) | Three Months Ended December 31, | Year Ended December 31, | |||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Net income (loss) attributable to Common Stockholders | $ | 4.2 | $ | 0.1 | $ | 18.4 | $ | 23.9 | |||||||
Add: net (loss) income attributable to noncontrolling interests | 0.4 | 0.4 | 1.7 | 6.0 | |||||||||||
Less: net income from discontinued operations | — | 9.3 | — | 43.8 | |||||||||||
Income (loss) from continuing operations | $ | 4.6 | $ | (8.8 | ) | $ | 20.1 | $ | (13.9 | ) | |||||
Corporate debt related interest expense(1) | 4.8 | 4.9 | 19.7 | 18.2 | |||||||||||
Consolidated income tax expense (benefit) | 5.3 | (4.4 | ) | 9.0 | (5.9 | ) | |||||||||
Depreciation and amortization expense(2) | 3.6 | 3.4 | 13.1 | 11.6 | |||||||||||
Non-cash fair value adjustments(3) | (0.7 | ) | (0.5 | ) | (3.1 | ) | (0.4 | ) | |||||||
Non-recurring expenses(4) | 1.7 | 0.3 | 4.2 | 2.4 | |||||||||||
Adjusted EBITDA from continuing operations | $ | 19.3 | $ | (5.1 | ) | $ | 63.0 | $ | 12.0 | ||||||
Add: Stock based compensation expense | 1.9 | 2.9 | 6.4 | 6.7 | |||||||||||
Add: Vessel depreciation, net of capital expenditures | 1.0 | 0.9 | 2.9 | 0.9 | |||||||||||
Less: Realized and unrealized gains (losses)(5) | 1.1 | (18.1 | ) | 8.6 | (34.7 | ) | |||||||||
Less: Third party non-controlling interests(6) | 0.1 | 0.2 | 0.1 | — | |||||||||||
Operating EBITDA from continuing operations | $ | 21.0 | $ | 16.6 | $ | 63.6 | $ | 54.3 | |||||||
Income (loss) from discontinued operations | $ | — | $ | 9.3 | $ | — | $ | 43.8 | |||||||
Consolidated income tax expense (benefit) | — | 1.4 | — | 13.7 | |||||||||||
Non-cash fair value adjustments (3) | — | — | — | (40.7 | ) | ||||||||||
Adjusted EBITDA from discontinued operations | $ | — | $ | 10.7 | $ | — | $ | 16.8 | |||||||
Less: Realized and unrealized gains (losses) (5) | — | 10.7 | — | 16.2 | |||||||||||
Operating EBITDA from discontinued operations | $ | — | $ | — | $ | — | $ | 0.6 | |||||||
Total Adjusted EBITDA | $ | 19.3 | $ | 5.6 | $ | 63.0 | $ | 28.8 | |||||||
Total Operating EBITDA | $ | 21.0 | $ | 16.6 | $ | 63.6 | $ | 54.9 | |||||||
(1) | Corporate debt interest expense includes interest expense from secured corporate credit agreements, junior subordinated notes and preferred trust securities. Interest expense associated with asset-specific debt in Tiptree Insurance and Tiptree Capital is not added-back for Adjusted EBITDA and Operating EBITDA. |
(2) | Represents total depreciation and amortization expense less purchase accounting amortization related adjustments at our insurance companies. Following the purchase accounting adjustments, current period expenses associated with deferred costs were more favorably stated and current period income associated with deferred revenues were less favorably stated. Thus, the purchase accounting effect related to our insurance companies increased EBITDA above what the historical basis of accounting would have generated. |
(3) | For our insurance operations, depreciation and amortization on senior living real estate that is within net investment income is added back to Adjusted EBITDA. For Care (Discontinued Operations), the reduction in EBITDA is related to accumulated depreciation and amortization, and certain operating expenses, which were previously included in Adjusted EBITDA in prior periods. |
(4) | Acquisition, start-up and disposition costs, including debt extinguishment, legal, taxes, banker fees and other costs. In 2018, includes payments pursuant to a separation agreement, dated November 10, 2015. |
(5) | Adjustment excludes Mortgage realized and unrealized gains and losses - Performing and NPLs, as those are recurring in nature and align with those business models. |
(6) | Removes the Operating EBITDA associated with third party non-controlling interests. Does not remove the non-controlling interests related to employee based shares. |
Three Months Ended December 31, 2019 | |||||||||||||||
($ in millions) | Specialty Insurance | Tiptree Capital | Corporate Expenses | Total | |||||||||||
Pre-tax income/(loss) from continuing operations | $ | 12.6 | $ | 4.8 | $ | (7.5 | ) | $ | 9.9 | ||||||
Adjustments: | |||||||||||||||
Corporate debt related interest expense(2) | 3.3 | — | 1.5 | 4.8 | |||||||||||
Depreciation and amortization expenses(3) | 2.1 | 1.3 | 0.2 | 3.6 | |||||||||||
Non-cash fair value adjustments(4) | — | (0.7 | ) | — | (0.7 | ) | |||||||||
Non-recurring expenses(5) | 2.0 | — | (0.3 | ) | 1.7 | ||||||||||
Adjusted EBITDA | $ | 20.0 | $ | 5.4 | $ | (6.1 | ) | $ | 19.3 | ||||||
Add: Stock-based compensation expense | 1.1 | — | 0.8 | 1.9 | |||||||||||
Add: Vessel depreciation, net of capital expenditures | — | 1.0 | — | 1.0 | |||||||||||
Less: Realized and unrealized gain (loss)(6) | 2.3 | (1.2 | ) | — | 1.1 | ||||||||||
Less: Third party non-controlling interests(7) | — | 0.1 | — | 0.1 | |||||||||||
Operating EBITDA | $ | 18.8 | $ | 7.5 | $ | (5.3 | ) | $ | 21.0 | ||||||
Year Ended December 31, 2019 | |||||||||||||||
($ in millions) | Tiptree Insurance | Tiptree Capital | Corporate Expenses | Total | |||||||||||
Pre-tax income/(loss) from continuing operations | $ | 41.0 | $ | 21.0 | $ | (32.9 | ) | $ | 29.1 | ||||||
Adjustments: | |||||||||||||||
Corporate debt related interest expense(2) | 13.4 | — | 6.3 | 19.7 | |||||||||||
Depreciation and amortization expense(3) | 8.6 | 3.8 | 0.7 | 13.1 | |||||||||||
Non-cash fair value adjustments(4) | — | (3.1 | ) | — | (3.1 | ) | |||||||||
Non-recurring expenses(5) | 3.7 | 0.2 | 0.3 | 4.2 | |||||||||||
Adjusted EBITDA | $ | 66.7 | $ | 21.9 | $ | (25.6 | ) | $ | 63.0 | ||||||
Add: Stock based compensation expense | 3.1 | 0.2 | 3.1 | 6.4 | |||||||||||
Add: Vessel depreciation, net of capital expenditures | — | 2.9 | — | 2.9 | |||||||||||
Less: Realized and unrealized gains (losses)(6) | 6.5 | 2.1 | — | 8.6 | |||||||||||
Less: Third party non-controlling interests(7) | — | 0.1 | — | 0.1 | |||||||||||
Operating EBITDA | $ | 63.3 | $ | 22.8 | $ | (22.5 | ) | $ | 63.6 | ||||||
Three Months Ended December 31, 2018 | |||||||||||||||
($ in millions) | Specialty Insurance | Tiptree Capital | Corporate Expenses | Total | |||||||||||
Pre-tax income/(loss) from continuing operations | $ | 2.8 | $ | (6.6 | ) | $ | (9.4 | ) | $ | (13.2 | ) | ||||
Pre-tax income/(loss) from discontinued operations(1) | — | 10.7 | — | 10.7 | |||||||||||
Adjustments: | |||||||||||||||
Corporate debt related interest expense(2) | 3.2 | — | 1.7 | 4.9 | |||||||||||
Depreciation and amortization expenses(3) | 2.2 | 1.1 | 0.1 | 3.4 | |||||||||||
Non-cash fair value adjustments(4) | — | (0.5 | ) | — | (0.5 | ) | |||||||||
Non-recurring expenses(5) | 0.3 | (1.5 | ) | 1.5 | 0.3 | ||||||||||
Adjusted EBITDA | $ | 8.5 | $ | 3.2 | $ | (6.1 | ) | $ | 5.6 | ||||||
Add: Stock-based compensation expense | 1.9 | — | 1.0 | 2.9 | |||||||||||
Add: Vessel depreciation, net of capital expenditures | — | 0.9 | — | 0.9 | |||||||||||
Less: Realized and unrealized gain (loss)(6) | (9.0 | ) | 1.6 | — | (7.4 | ) | |||||||||
Less: Third party non-controlling interests(7) | — | 0.2 | — | 0.2 | |||||||||||
Operating EBITDA | $ | 19.4 | $ | 2.3 | $ | (5.1 | ) | $ | 16.6 | ||||||
Year Ended December 31, 2018 | |||||||||||||||
($ in millions) | Tiptree Insurance | Tiptree Capital | Corporate Expenses | Total | |||||||||||
Pre-tax income/(loss) from continuing operations | $ | 18.6 | $ | (7.8 | ) | $ | (30.6 | ) | $ | (19.8 | ) | ||||
Pre-tax income/(loss) from discontinued operations(1) | — | 57.5 | — | 57.5 | |||||||||||
Adjustments: | |||||||||||||||
Corporate debt related interest expense(2) | 13.2 | — | 5.0 | 18.2 | |||||||||||
Depreciation and amortization expenses(3) | 9.8 | 1.6 | 0.2 | 11.6 | |||||||||||
Non-cash fair value adjustments(4) | — | (41.1 | ) | — | (41.1 | ) | |||||||||
Non-recurring expenses(5) | 3.1 | — | (0.7 | ) | 2.4 | ||||||||||
Adjusted EBITDA | $ | 44.7 | $ | 10.2 | $ | (26.1 | ) | $ | 28.8 | ||||||
Add: Stock based compensation expense | 3.8 | 0.1 | 2.8 | 6.7 | |||||||||||
Add: Vessel depreciation, net of capital expenditures | — | 0.9 | — | 0.9 | |||||||||||
Less: Realized and unrealized gains (losses)(6) | (16.0 | ) | (2.5 | ) | — | (18.5 | ) | ||||||||
Less: Third party non-controlling interests(7) | — | — | — | — | |||||||||||
Operating EBITDA | $ | 64.5 | $ | 13.7 | $ | (23.3 | ) | $ | 54.9 | ||||||
(1) | Includes discontinued operations related to Care. For more information, see “Note—(3) Dispositions, Assets Held for Sale & Discontinued Operations” in our Form 10-K for the year ended December 31, 2019. |
(2) | Corporate debt interest expense includes interest expense from secured corporate credit agreements, junior subordinated notes and preferred trust securities. Interest expense associated with asset-specific debt in Tiptree Insurance and Tiptree Capital is not added-back for Adjusted EBITDA and Operating EBITDA. |
(3) | Represents total depreciation and amortization expense less purchase accounting amortization related adjustments at our insurance companies. Following the purchase accounting adjustments, current period expenses associated with deferred costs were more favorably stated and current period income associated with deferred revenues were less favorably stated. Thus, the purchase accounting effect related to our insurance companies increased EBITDA above what the historical basis of accounting would have generated. |
(4) | For our insurance operations, depreciation and amortization on senior living real estate that is within net investment income is added back to Adjusted EBITDA. For Care (Discontinued Operations), the reduction in EBITDA is related to accumulated depreciation and amortization, and certain operating expenses, which were previously included in Adjusted EBITDA in prior periods. |
(5) | Acquisition, start-up and disposition costs, including debt extinguishment, legal, taxes, banker fees and other costs. In 2018, includes payments pursuant to a separation agreement, dated November 10, 2015. |
(6) | Adjustment excludes Mortgage realized and unrealized gains and losses - Performing and NPLs, as those are recurring in nature and align with those business models. |
(7) | Removes the Operating EBITDA associated with third party non-controlling interests. Does not remove the non-controlling interests related to employee based shares. |
($ in millions, except per share information) | As of December 31, | ||||||
2019 | 2018 | ||||||
Total stockholders’ equity | $ | 411.5 | $ | 399.3 | |||
Less non-controlling interests - other | 13.4 | 12.2 | |||||
Total stockholders’ equity, net of non-controlling interests - other | $ | 398.1 | $ | 387.1 | |||
Total Common Shares outstanding | 34.6 | 35.9 | |||||
Book value per share | $ | 11.52 | $ | 10.79 | |||